GlassScriptPhysician profile
Crystal Truong
NPI 1720540404
$3,352.63
in general payments reported to CMS, 2019-2025
16 companies · $1,290 in 2025
The $1,290 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.99 · 2021: $1,024 · 2022: $481 · 2023: $349 · 2024: $109 · 2025: $1,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $853.66 | 2021 | |
| Alcon Vision LLC | $566.85 | 2021-2025 | Clareon, Clareon Panoptix Pro |
| Tarsus Pharmaceuticals, INC. | $398.61 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $264.58 | 2022-2025 | |
| Rxsight INC | $249.67 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Sight Sciences, INC. | $236.99 | 2022-2025 | Omni Surgical System, Tearcare System |
| Johnson & Johnson Surgical Vision, INC. | $176.25 | 2025 | Tecnis Iol |
| Bausch & Lomb Americas INC. | $140.98 | 2024-2025 | Xiidra, Miebo |
| Abbvie INC. | $116.55 | 2023-2025 | Durysta |
| Allergan, INC. | $99.99 | 2020 | |
| Nova Eye, INC. | $86.69 | 2025 | |
| New World Medical,INC. | $50.67 | 2023-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Dompe US, INC. | $34.34 | 2025 | Oxervate |
| Amgen INC. | $28.49 | 2024 | Tepezza |
| Biotissue Holdings INC. | $26.77 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $21.54 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Truong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.